CTI BioPharma Corp

-0.03 (-0.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)755.03M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$24.64 Million
Adjusted EPS-$0.09
See more estimates
10-Day MA$5.83
50-Day MA$5.41
200-Day MA$5.34
See more pivots

CTI BioPharma Corp Stock, NASDAQ:CTIC

3101 Western Avenue, Suite 800, Seattle, Washington 98121
United States of America
Phone: +
Number of Employees: 121


CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.